検索キーワード： 著者 "Foreign Policy" すべてのカテゴリー

On State of Seed, you’ll find out how seeds feed and sustain the planet. Though more than half of what we eat comes from seeds, most of us know very little about them—and how the sector contributes to our world and the future of food security. Host Laura Rosbrow-Telem talks to the innovative players advancing this vital resource, including leaders of multinational companies and NGOs, UN and government officials, entrepreneurs, national seed associations, scientists, and of course, farmers. Plus, you’ll hear about the key concerns keeping them up at night. State of Seed is brought to you ...

In 2014, American private contractor Alan Gross was rotting in a Cuban prison, convicted of undermining the Havana regime. At that same time, Cuban intelligence agent Gerardo Hernández was serving two life sentences in a US federal penitentiary on charges related to espionage. Then, it all changed. I Spy: The U.S., Cuba, and the Secret Deal That Ended the Cold War describes how secret negotiations to free the two men helped bring an end to half a century of hostilities between the United States and Cuba.

Spies don’t talk—it’s the cardinal rule of the business. But on Foreign Policy’s podcast I Spy, we get them to open up. We hear from the operations people: the spies who steal secrets, kill adversaries, and turn agents into double agents. Each episode features one spy telling one dramatic story. And now, with I Spy Plus, get deeper into each subject's story with additional interview excerpts, interviews with experts, and behind-the-scenes looks into the production of the show. Access all of your I Spy Plus benefits by logging in your account at foreignpolicy.com/ispy.

Is it possible to end HIV and global health epidemics as public health threats by 2030? The United Nations thinks so, and the guests on this podcast series certainly hope so. But it’s going to take effort, innovation, connections between people and within communities and funding. Welcome to Can We End Epidemics?, a podcast series by the global biopharmaceutical company ViiV Healthcare in association with its biopharma majority shareholder GSK and developed by FP Studios.